Disease-specific formulas are further subdivided into diabetic, renal, hepatic, pulmonary, and Others formulas, which primarily include immune-enhancing & wound-healing formulas and formulas for critical care. On the basis of stage, the market is segmented into adults and pediatrics. On the basis of application, the market is segmented into oncology, gastroenterology, neurology, diabetes, critical care, and Others applications. Others applications primarily include diseases and disorders of the heart, renal system, lungs, and liver, along with psychiatric disorders. The oncology application segment held the largest share of the enteral feeding formulas market in 2015, primarily due to the high prevalence of malnutrition among cancer patients. By end user, the market is segmented into hospitals and long-term care facilities. Long-term care facilities are further divided into homecare agencies & hospices, nursing homes, and assisted living facilities. The market is mainly driven by the rising incidences of chronic diseases and disorders, the rapidly increasing geriatric population, increasing healthcare expenditure, rising prevalence of preterm births, and increasing demand for homecare. On the Others hand, factors such as complications associated with enteral nutrition, patient safety risks, and the risk of feeding and medication errors are some factors that are expected to limit the growth of the enteral feeding formulas market in the coming years. Market Analysis and Insights: Global Enteral Feeding Formulas Market The global Enteral Feeding Formulas market size is projected to reach US$ 6002.2 million by 2027, from US$ 4452.4 million in 2020, at a CAGR of 4.3% during 2021-2027. With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Enteral Feeding Formulas market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Enteral Feeding Formulas market in terms of revenue. On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Enteral Feeding Formulas market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Enteral Feeding Formulas market. Global Enteral Feeding Formulas Scope and Market Size Enteral Feeding Formulas market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Enteral Feeding Formulas market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027. Segment by Type Adults Pediatrics Segment by Application Oncology Gastroenterology Neurology Diabetes Critical Care Others Applications By Region North America U.S. Canada Europe Germany France U.K. Italy Russia Nordic Rest of Europe Asia-Pacific China Japan South Korea Southeast Asia India Australia Rest of Asia Latin America Mexico Brazil Rest of Latin America Middle East & Africa Turkey Saudi Arabia UAE Rest of MEA By Company Abbott Laboratories Nestle Danone Fresenius Kabi Mead Johnson Nutrition Company B.Braun Melsungen Hormel Foods Corporation Meiji Holdings Victus Global Health Products
1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Enteral Feeding Formulas Market Size Growth Rate by Type: 2016 VS 2021 VS 2027 1.2.2 Adults 1.2.3 Pediatrics 1.3 Market by Application 1.3.1 Global Enteral Feeding Formulas Market Share by Application: 2016 VS 2021 VS 2027 1.3.2 Oncology 1.3.3 Gastroenterology
